Abstract P6-07-11: Health economic impact of breast cancer index (BCI) for late disease management in patients with estrogen receptor-positive, node-negative breast cancer

Abstract P4-08-27: The 21-gene Recurrence® (RS) Score assay in estrogen receptor positive node negative breast cancer: Real-world chemotherapy usage and patient characteristics within the intermediate and high-risk RS category

10.1158/1538-7445.sabcs18-p4-08-27 ◽

2019 ◽

Author(s):

D Le ◽

S Chia ◽

C Simmons ◽

C Speers ◽

L Gondara ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

High Risk ◽

Real World ◽

Patient Characteristics ◽

Positive Node ◽

Node Negative ◽

Abstract P6-08-10: Prospective study of the impact of the Prosigna™ assay on adjuvant clinical decision-making in women with estrogen receptor-positive, HER2-negative, node-negative breast cancer: A GEICAM study

10.1158/1538-7445.sabcs14-p6-08-10 ◽

2015 ◽

Cited By ~ 1

Author(s):

Miguel Martín ◽

Milagros González-Rivera ◽

Serafín Morales ◽

Juan de la Haba ◽

Lucía González-Cortijo ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Estrogen Receptor ◽

Prospective Study ◽

Clinical Decision Making ◽

Clinical Decision ◽

Node Negative ◽

Estrogen Receptor Positive ◽

The Impact

Abstract P5-08-03: Prognostic impact of the combined risk groups by breast cancer index and HOXB13/IL17BR ratio in hormonal receptor positive, node negative breast cancer: A TransATAC study

10.1158/1538-7445.sabcs15-p5-08-03 ◽

2016 ◽

Author(s):

Y Zhang ◽

I Sestak ◽

BE Schroeder ◽

M Dowsett ◽

J Cuzick ◽

...

Keyword(s):

Breast Cancer ◽

Risk Groups ◽

Positive Node ◽

Prognostic Impact ◽

Node Negative ◽

Hormonal Receptor ◽

Breast Cancer Index ◽

Node Negative Breast Cancer

Abstract P2-08-01: Prospective trial of endocrine therapy alone in patients with estrogen receptor positive, HER2-negative, node-negative breast cancer: Results of the TAILORx low risk registry

10.1158/1538-7445.sabcs15-p2-08-01 ◽

2016 ◽

Cited By ~ 1

Author(s):

JA Sparano ◽

RJ Gray ◽

DF Makower ◽

KI Pritchard ◽

KS Albain ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Therapy ◽

Prospective Trial ◽

Low Risk ◽

Node Negative ◽

325 PUBLICATION Prognostic relevance of HER2 expression and gene amplification in estrogen receptor-positive lymph-node negative breast cancer patients

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)80623-8 ◽

2005 ◽

Vol 3 (2) ◽

pp. 91

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Lymph Node ◽

Cancer Patients ◽

Positive Lymph Node ◽

Her2 Expression ◽

Breast Cancer Patients ◽

Node Negative ◽

Ki‑67 index value and progesterone receptor status can predict prognosis and suitable treatment in node‑negative breast cancer patients with estrogen receptor‑positive and HER2‑negative tumors

Oncology Letters ◽

10.3892/ol.2018.9633 ◽

2018 ◽

Cited By ~ 2

Author(s):

Nobuyuki Arima ◽

Reiki Nishimura ◽

Tomofumi Osako ◽

Yasuhiro Okumura ◽

Masahiro Nakano ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Progesterone Receptor Status ◽

Breast Cancer Patients ◽

Ki 67 ◽

Node Negative ◽

Estrogen Receptor Positive ◽

Suitable Treatment ◽

Index Value

A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors

New England Journal of Medicine ◽

10.1056/nejm198902233200802 ◽

1989 ◽

Vol 320 (8) ◽

pp. 479-484 ◽

Cited By ~ 1043

Author(s):

Bernard Fisher ◽

Joseph Costantino ◽

Carol Redmond ◽

Roger Poisson ◽

David Bowman ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Estrogen Receptor ◽

Randomized Clinical Trial ◽

Node Negative ◽

Disease recurrence and oncological outcome of patients treated surgically with curative intent for estrogen receptor positive, lymph node negative breast cancer

Surgical Oncology ◽

10.1016/j.suronc.2021.101531 ◽

2021 ◽

Vol 37 ◽

pp. 101531

Author(s):

M.G. Davey ◽

É.J. Ryan ◽

P.F. McAnena ◽

M.R. Boland ◽

M.K. Barry ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Lymph Node ◽

Oncological Outcome ◽

Disease Recurrence ◽

Positive Lymph Node ◽

Curative Intent ◽

Node Negative ◽

Factors That Predict Biological Aggressiveness in Estrogen Receptor–Positive / Human Epidermal Growth Factor Receptor 2–Negative / Lymph Node–Negative Breast Cancer

Ochsner Journal ◽

10.31486/toj.20.0035 ◽

2020 ◽

Vol 20 (4) ◽

pp. 381-387

Author(s):

Lauren E. Arthur ◽

Ashley H. McMann ◽

Lauren N. Slattery ◽

George M. Fuhrman ◽

Aimee M. Mackey ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Epidermal Growth Factor Receptor ◽

Lymph Node ◽

Growth Factor ◽

Growth Factor Receptor ◽

Node Negative ◽

Estrogen Receptor Positive ◽

Epidermal Growth

P4-02-06: Progesterone Receptor Expression Predicts Poor Outcome in Estrogen Receptor Positive, Lymph Node Negative Breast Cancer – A Population Based Study.

10.1158/0008-5472.sabcs11-p4-02-06 ◽

2011 ◽

Author(s):

CA Purdie ◽

P Quinlan ◽

LB Jordan ◽

A Ashfield ◽

L Baker ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Population Based ◽

Positive Lymph Node ◽

Receptor Expression ◽

Progesterone Receptor Expression ◽

Population Based Study ◽

Node Negative ◽